Blood protein levels and inflammation in bowel disease

Researchers studied a protein in the blood called leucine-rich alpha-2 glycoprotein to see if it could help detect active ulcerative colitis or Crohn's disease. The trial examined whether measuring this protein level in serum (blood) was useful for identifying patients whose bowel disease was actively inflamed. The researchers compared blood test results with colonoscopy findings to understand if this simple blood test could reliably show disease activity.

Doctors currently use uncomfortable procedures like colonoscopies and complex scoring systems to assess whether a patient's bowel disease is actively inflamed. This study investigated whether a simple blood test measuring this protein could offer a faster, less invasive way to monitor disease activity and help guide treatment decisions.